ScienceDex / Researcher record
Jorge Silvio Gutkind
- University of California, San Diego · Pharmacology (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Translational
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $3,263,353 | 6 | #2,262 |
| 2025 | $3,339,667 | 6 | #2,832 |
| 2026 | $3,021,054 | 5 | #6,121 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20246 records
- FY2025 · selected6 records
- FY20265 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2028219Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-5150-4482Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- OTHER BASIC SCIENCES
- Pharmacology
FY2025 award records by amount
NIH award records listing Jorge Silvio Gutkind as a PI. Multi-PI records show the full award amount for context.
- 5U01CA290479-03U01Co-investigatorMapping immuno-genomic drivers of the head and neck precancer invasive-disease transitionUniversity of California, San Diego · Other Basic Sciences (NIH department code)$790Kaward amount
- 5R01DE033909-02R01Contact PIReprogramming the Tumor Immune Microenvironment with Chemokines to Potentiate Immune Oncology Treatments in Oral CancerUniversity of California, San Diego · Pharmacology (NIH department code)$585.6Kaward amount
- 5R01CA257505-05R01Contact PITargeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal MelanomaUniversity of California, San Diego · Pharmacology (NIH department code)$522.1Kaward amount
- 5R01DE030497-05R01Co-investigatorSignal Transduction by PI3K/mTORUniversity of California, San Diego · Pharmacology (NIH department code)$483.5Kaward amount
- 1R01DE035393-01R01Contact PITargeting Systems Vulnerabilities in the EGFR/HER3/HER2 Oncogenic Signaling Circuitry: New Precision Therapies for Oral CancerUniversity of California, San Diego · Pharmacology (NIH department code)$483.4Kaward amount
- 5R01DE026644-09R01Contact PITargeting Signaling Vulnerabilities for Oral Cancer PreventionUniversity of California, San Diego · Pharmacology (NIH department code)$475.1Kaward amount
Award organization
Organizations that administered FY2025 awards listing Jorge Silvio Gutkind as a PI.
FY2025 award administered by University of California, San Diego (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California, San Diego
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2262
- 2024Entered Top 25% NationallyRanked #2262
- 2025$5M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jorge Silvio Gutkind.